|
1
|
Fitzmaurice C, Akinyemiju TF, Al Lami FH,
Alam T, Alizadeh-Navaei R, Allen C, Alsharif U, Alvis-Guzman N,
Amini E, Anderson BO, et al Global Burden of Disease Cancer
Collaboration, : Global, Regional, and National Cancer Incidence,
Mortality, Years of Life Lost, Years Lived With Disability, and
Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016:
A Systematic Analysis for the Global Burden of Disease Study. JAMA
Oncol. 4:1553–1568. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Watanabe T, Itabashi M, Shimada Y, Tanaka
S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, et
al: Foundation for Promotion of Cancer Research. Cancer Statics in
Japan-2014. The Editorial Board of the Cancer Statics in Japan
(eds.), . FPCR c/o National Cancer Center. (Tokyo). 1–114.
2015.
|
|
3
|
Watanabe T, Itabashi M, Shimada Y, Tanaka
S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, et
al Japanese Society for Cancer of the Colon and Rectum, : Japanese
Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014
for treatment of colorectal cancer. Int J Clin Oncol. 20:207–239.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Skibber JM, Hoff PM and Minsky BD: Cancer
of the rectum. Cancer: Principles and Practice of Oncology (6th
edition). Devita VT, Hellman S and Rosenberg SA: Lippincott,
Williams and Wilkins. (Philadelphia). 1271–1318. 2001.
|
|
5
|
Francois Y, Nemoz CJ, Baulieux J, Vignal
J, Grandjean JP, Partensky C, Souquet JC, Adeleine P and Gerard JP:
Influence of the interval between preoperative radiation therapy
and surgery on downstaging and on the rate of sphincter-sparing
surgery for rectal cancer: The Lyon R90-01 randomized trial. J Clin
Oncol. 17:2396–2402. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wong CS, Cummings BJ, Brierley JD, Catton
CN, McLean M, Catton P and Hao Y: Treatment of locally recurrent
rectal carcinoma--results and prognostic factors. Int J Radiat
Oncol Biol Phys. 40:427–435. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lingareddy V, Ahmad NR and Mohiuddin M:
Palliative reirradiation for recurrent rectal cancer. Int J Radiat
Oncol Biol Phys. 38:785–790. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cedermark B, Dahlberg M, Glimelius B,
Påhlman L, Rutqvist LE and Wilking N; Swedish Rectal Cancer Trial,
: Improved survival with preoperative radiotherapy in resectable
rectal cancer. N Engl J Med. 336:980–987. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cammà C, Giunta M, Fiorica F, Pagliaro L,
Craxì A and Cottone M: Preoperative radiotherapy for resectable
rectal cancer: A meta-analysis. JAMA. 284:1008–1015. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Colorectal Cancer Collaborative Group, :
Adjuvant radiotherapy for rectal cancer: A systematic overview of
22 randomised trials involving 8507 patients. Lancet.
358:1291–1304. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kapiteijn E, Marijnen CA, Nagtegaal ID,
Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B,
van Krieken JH, et al Dutch Colorectal Cancer Group, : Preoperative
radiotherapy combined with total mesorectal excision for resectable
rectal cancer. N Engl J Med. 345:638–646. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peeters KC, Marijnen CA, Nagtegaal ID,
Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius
B, Leer JW, et al Dutch Colorectal Cancer Group, : The TME trial
after a median follow-up of 6 years: Increased local control but no
survival benefit in irradiated patients with resectable rectal
carcinoma. Ann Surg. 246:693–701. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van Gijn W, Marijnen CA, Nagtegaal ID,
Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius
B and van de Velde CJ; Dutch Colorectal Cancer Group, :
Preoperative radiotherapy combined with total mesorectal excision
for resectable rectal cancer: 12-year follow-up of the multicentre,
randomised controlled TME trial. Lancet Oncol. 12:575–582. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kulka U, Schaffer M, Siefert A, Schaffer
PM, Olsner A, Kasseb K, Hofstetter A, Dühmke E and Jori G:
Photofrin as a radiosensitizer in an in vitro cell survival assay.
Biochem Biophys Res Commun. 311:98–103. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marijnen CA, Kapiteijn E, van de Velde CJ,
Martijn H, Steup WH, Wiggers T, Kranenbarg EK and Leer JW;
Cooperative Investigators of the Dutch Colorectal Cancer Group, :
Acute side effects and complications after short-term preoperative
radiotherapy combined with total mesorectal excision in primary
rectal cancer: Report of a multicenter randomized trial. J Clin
Oncol. 20:817–825. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cox JD, Stetz J and Pajak TF: Toxicity
criteria of the Radiation Therapy Oncology Group (RTOG) and the
European Organization for Research and Treatment of Cancer (EORTC).
Int J Radiat Oncol Biol Phys. 31:1341–1346. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marijnen CA, van de Velde CJ, Putter H,
van den Brink M, Maas CP, Martijn H, Rutten HJ, Wiggers T,
Kranenbarg EK, Leer JW, et al: Impact of short-term preoperative
radiotherapy on health-related quality of life and sexual
functioning in primary rectal cancer: Report of a multicenter
randomized trial. J Clin Oncol. 23:1847–1858. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peeters KC, van de Velde CJ, Leer JW,
Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T,
Rutten HJ and Marijnen CA: Late side effects of short-course
preoperative radiotherapy combined with total mesorectal excision
for rectal cancer: Increased bowel dysfunction in irradiated
patients--a Dutch colorectal cancer group study. J Clin Oncol.
23:6199–6206. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ishizuka M, Abe F, Sano Y, Takahashi K,
Inoue K, Nakajima M, Kohda T, Komatsu N, Ogura S and Tanaka T:
Novel development of 5-aminolevurinic acid (ALA) in cancer
diagnoses and therapy. Int Immunopharmacol. 11:358–365. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng Q, Warloe T, Berg K, Moan J,
Kongshaug M, Giercksky KE and Nesland JM: 5-Aminolevulinic
acid-based photodynamic therapy. Clinical research and future
challenges. Cancer. 79:2282–2308. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hagiya Y, Fukuhara H, Matsumoto K, Endo Y,
Nakajima M, Tanaka T, Okura I, Kurabayashi A, Furihata M, Inoue K,
et al: Expression levels of PEPT1 and ABCG2 play key roles in
5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin
IX (PpIX) accumulation in bladder cancer. Photodiagn Photodyn Ther.
10:288–295. 2013. View Article : Google Scholar
|
|
22
|
Dougherty TJ, Gomer CJ, Henderson BW, Jori
G, Kessel D, Korbelik M, Moan J and Peng Q: Photodynamic therapy. J
Natl Cancer Inst. 90:889–905. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Utsuki S, Miyoshi N, Oka H, Miyajima Y,
Shimizu S, Suzuki S and Fujii K: Fluorescence-guided resection of
metastatic brain tumors using a 5-aminolevulinic acid-induced
protoporphyrin IX: Pathological study. Brain Tumor Pathol.
24:53–55. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fukuhara H, Inoue K, Satake H, Tamura K,
Karashima T, Yamasaki I, Tatsuo I, Kurabayashi A, Furihata M and
Shuin T: Photodynamic diagnosis of positive margin during radical
prostatectomy: Preliminary experience with 5-aminolevulinic acid.
Int J Urol. 18:585–591. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mimura S, Ito Y, Nagayo T, Ichii M, Kato
H, Sakai H, Goto K, Noguchi Y, Tanimura H, Nagai Y, et al:
Cooperative clinical trial of photodynamic therapy with photofrin
II and excimer dye laser for early gastric cancer. Lasers Surg Med.
19:168–172. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Corti L, Toniolo L, Boso C, Colaut F,
Fiore D, Muzzio PC, Koukourakis MI, Mazzarotto R, Pignataro M,
Loreggian L, et al: Long-term survival of patients treated with
photodynamic therapy for carcinoma in situ and early non-small-cell
lung carcinoma. Lasers Surg Med. 39:394–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao LQ, Xue P, Lu HW, Zheng Q, Wen ZL and
Shao ZJ: Hematoporphyrin derivative-mediated photodynamic therapy
inhibits tumor growth in human cholangiocarcinoma in vitro and in
vivo. Hepatol Res. 39:1190–1197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luksiene Z, Kalvelyte A and Supino R: On
the combination of photodynamic therapy with ionizing radiation. J
Photochem Photobiol B. 52:35–42. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schaffer M, Schaffer PM, Corti L, Gardiman
M, Sotti G, Hofstetter A, Jori G and Dühmke E: Photofrin as a
specific radiosensitizing agent for tumors: Studies in comparison
to other porphyrins, in an experimental in vivo model. J Photochem
Photobiol B. 66:157–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamamoto J, Ogura S, Tanaka T, Kitagawa T,
Nakano Y, Saito T, Takahashi M, Akiba D and Nishizawa S:
Radiosensitizing effect of 5-aminolevulinic acid-induced
protoporphyrin IX in glioma cells in vitro. Oncol Rep.
27:1748–1752. 2012.PubMed/NCBI
|
|
31
|
Takahashi J, Misawa M, Murakami M, Mori T,
Nomura K and Iwahashi H: 5-Aminolevulinic acid enhances cancer
radiotherapy in a mouse tumor model. Springerplus. 2:6022013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamamoto J, Ogura S, Shimajiri S, Nakano
Y, Akiba D, Kitagawa T, Ueta K, Tanaka T and Nishizawa S:
5-aminolevulinic acid-induced protoporphyrin IX with multi-dose
ionizing irradiation enhances host antitumor response and strongly
inhibits tumor growth in experimental glioma in vivo. Mol
Med Rep. 11:1813–1819. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kitagawa T, Yamamoto J, Tanaka T, Nakano
Y, Akiba D, Ueta K and Nishizawa S: 5-Aminolevulinic acid strongly
enhances delayed intracellular production of reactive oxygen
species (ROS) generated by ionizing irradiation: Quantitative
analyses and visualization of intracellular ROS production in
glioma cells in vitro. Oncol Rep. 33:583–590. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Capella MA and Capella LS: A light in
multidrug resistance: Photodynamic treatment of multidrug-resistant
tumors. J Biomed Sci. 10:361–366. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dolmans DE, Fukumura D and Jain RK:
Photodynamic therapy for cancer. Nat Rev Cancer. 3:380–387. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vrouenraets MB, Visser GW, Snow GB and van
Dongen GA: Basic principles, applications in oncology and improved
selectivity of photodynamic therapy. Anticancer Res. 23((1B)):
505–522. 2003.PubMed/NCBI
|
|
37
|
Hall EJ and Giaccia AJ: Physics and
chemistry of radiation absorption. Radiobiology for the Radiologist
(6th edition). Hall EJ and Giaccia AJ: Lippincott Williams &
Wilkins. (Philadelphia, PA). 5–15. 2006.
|
|
38
|
Hosokawa Y, Sakakura Y, Tanaka L, Okumura
K, Yajima T and Kaneko M: Radiation-induced apoptosis is
independent of caspase-8 but dependent on cytochrome c and the
caspase-9 cascade in human leukemia HL60 cells. J Radiat Res
(Tokyo). 46:293–303. 2005. View Article : Google Scholar
|
|
39
|
Yamamoto J, Yamamoto S, Hirano T, Li S,
Koide M, Kohno E, Okada M, Inenaga C, Tokuyama T, Yokota N, et al:
Monitoring of singlet oxygen is useful for predicting the
photodynamic effects in the treatment for experimental glioma. Clin
Cancer Res. 12:7132–7139. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Saenko Y, Cieslar-Pobuda A, Skonieczna M
and Rzeszowska-Wolny J: Changes of reactive oxygen and nitrogen
species and mitochondrial functioning in human K562 and HL60 cells
exposed to ionizing radiation. Radiat Res. 180:360–366. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yamamori T, Yasui H, Yamazumi M, Wada Y,
Nakamura Y, Nakamura H and Inanami O: Ionizing radiation induces
mitochondrial reactive oxygen species production accompanied by
upregulation of mitochondrial electron transport chain function and
mitochondrial con-tent undercontrol of the cell cycle checkpoint.
Free Radic Biol Med. 15;53(2): 260–70. 2012. View Article : Google Scholar
|
|
42
|
Hino H, Murayama Y, Nakanishi M, Inoue K,
Nakajima M and Otsuji E: 5-Aminolevulinic acid-mediated
photodynamic therapy using light-emitting diodes of different
wavelengths in a mouse model of peritoneally disseminated gastric
cancer. J Surg Res. 185:119–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Harris EER and Small W Jr: Intraoperative
Radiotherapy for Breast Cancer. Front Oncol. 7:3172017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shaw E, Scott C, Souhami L, Dinapoli R,
Kline R, Loeffler J and Farnan N: Single dose radiosurgical
treatment of recurrent previously irradiated primary brain tumors
and brain metastases: Final report of RTOG protocol 90–05. Int J
Radiat Oncol Biol Phys. 47:291–298. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pajonk F, Vlashi E and McBride WH:
Radiation resistance of cancer stem cells: The 4 R's of
radiobiology revisited. Stem Cells. 28:639–648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Withers HR: The four R's of radiotherapy.
Advances in radiation biology. Lett JTAH (ed). Academic Press. (New
York). 1975. View Article : Google Scholar
|
